Status:
UNKNOWN
Evaluation of the Predictors of Clinical and Radiological Response to Gamma-Knife Radiosurgery in the Treatment of Intermediate Ventral Nucleus of the Thalamus (VIM) Thalamotomy Tremor.
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Severe Disabling Tremor
Eligibility:
All Genders
20+ years
Brief Summary
Gamma-Knife radiosurgery of the VIM for patients presenting with severe drug-resistant tremor is now current practice as an alternative to Deep Brain Stimulation (DBS) of the VIM. Now, around 100 pat...
Eligibility Criteria
Inclusion
- Male or female aged 20 years minimum
- Patient with absolute contraindication or relative to deep brain stimulation (DBS) of VIM.
- Patient having the Gamma Knife radiosurgery of VIM (combining clinical and paraclinical conditions).
- Patient affiliated to a social security scheme.
- Patient having understood and signed the information notice for non opposition.
Exclusion
- Patient having a contraindication to performing a cerebral MRI (pace-maker, intracerebral metallic object etc.)
- Patient with a contraindication to radiosurgical treatment (previous treatment with cerebral radiotherapy)
- Vulnerable persons: minors, protected adults (guardianship or trusteeship) and adults unable to express their non-opposition.
Key Trial Info
Start Date :
October 23 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 22 2021
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT03350139
Start Date
October 23 2017
End Date
October 22 2021
Last Update
November 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13354